Cytomegaloviral Hepatitis (ICD Code: B25.1)

Name of the Condition

• Common Name: Cytomegaloviral Hepatitis
• Medical Term: CMV Hepatitis

Summary

Cytomegaloviral hepatitis is a liver inflammation caused by an infection with the cytomegalovirus (CMV). It primarily affects individuals with weakened immune systems, leading to varying degrees of liver dysfunction and related symptoms.

Causes

• Infection with the cytomegalovirus (CMV), a type of herpesvirus.
• Often occurs in individuals who have a compromised immune system, such as organ transplant recipients, individuals with HIV/AIDS, or those undergoing chemotherapy.

Risk Factors

• Immunocompromised status, including HIV infection, organ transplantation, or immunosuppressive therapy.
• Infants and neonates may be at risk if the mother has an active CMV infection during pregnancy.

Symptoms

• Jaundice (yellowing of the skin and eyes)
• Fatigue
• Fever
• Nausea and vomiting
• Abdominal pain, particularly in the upper right side
• Enlarged liver (hepatomegaly)

Diagnosis

• Blood tests to detect CMV antibodies or DNA.
• Liver function tests to assess liver enzyme levels.
• Liver biopsy to confirm viral presence and assess liver tissue damage.
• Imaging (e.g., ultrasound) to evaluate liver condition.

Treatment Options

• Antiviral medications such as ganciclovir or valganciclovir to reduce viral load.
• Managing symptoms with supportive care, such as pain relievers and anti-nausea medications.
• Monitoring and supportive care for liver function.

Prognosis and Follow-Up

• The prognosis largely depends on the individual's immune status and response to antiviral therapy.
• Regular follow-up is crucial for monitoring liver function and potential CMV reactivation, especially in immunocompromised patients.

Complications

• Chronic liver damage or cirrhosis if left untreated.
• Potential spread of CMV infection to other organs.
• Increased risk of organ rejection in transplant recipients.

Lifestyle & Prevention

• Maintaining a healthy immune system through balanced diet and regular exercise.
• Practicing safe hygiene measures to reduce transmission risk.
• Regular monitoring and early treatment in high-risk populations.

When to Seek Professional Help

• If experiencing symptoms of jaundice, persistent fever, or abdominal pain, especially if at risk for CMV hepatitis.
• Immediate medical attention is required for severe symptoms or signs of liver dysfunction.

Additional Resources

• Centers for Disease Control and Prevention (CDC) website
• American Liver Foundation website
• Patient support groups for individuals with liver diseases.

Tips for Medical Coders

• Ensure accurate differentiation between CMV hepatitis and other viral hepatitis conditions by referencing specific ICD-10 codes.
• Avoid common coding errors by verifying patient's immune status and confirming CMV as the infectious agent through medical records.